Form 4: Centene CEO Sarah London Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Centene CEO Sarah London reports the withholding of shares for taxes and adjustments to her holdings of common stock and derivative securities.
Summary
- On June 23, 2024, Sarah London, CEO of Centene Corp, reported changes in her beneficial ownership of the company's stock.
- 1,987 shares were withheld for taxes upon the vesting of previously-reported restricted stock units at a price of $67.93.
- Following the transaction, London directly owns 711,677 shares of Centene common stock.
- This includes 598,652 shares of previously-granted restricted stock units and performance stock units subject to vesting requirements.
- London also holds a performance stock option granted on December 15, 2021, which may become exercisable if Centene's stock price reaches $100 per share for 20 consecutive trading days after the grant date; this option covers 13,449 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing changes in beneficial ownership, which is neutral in sentiment. It reflects routine transactions related to executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates adjustments to the CEO's holdings due to tax obligations and vesting schedules, which are common occurrences.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units.
- The vesting schedules and performance-based conditions attached to these equity grants are typical in the healthcare industry and are designed to align executive incentives with shareholder value.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the CEO's stake in the company.
- It assures stakeholders that executive compensation is aligned with company performance through vesting requirements and performance-based stock options.
Key Dates
| Date | Description |
|---|---|
| 12/15/2021 | Date of performance stock option grant. |
| 06/23/2024 | Date of transaction (shares withheld for taxes). |
| 06/24/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.